Technical Analysis for VRNA - Verona Pharma plc
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 13.95 | 0.50% | 0.07 |
VRNA closed up 0.5 percent on Wednesday, May 15, 2024, on 76 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| New Downtrend | Bearish | 0.00% | |
| NR7 | Range Contraction | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| Lower Bollinger Band Walk | Weakness | 0.50% | |
| Below Lower BB | Weakness | 0.50% | |
| Lower Bollinger Band Touch | Weakness | 0.50% | |
| Oversold Stochastic | Weakness | 0.50% | |
| Expansion Breakdown | Bearish Swing Setup | 0.50% | |
| Below Lower BB | Weakness | 0.50% | |
| Lower Bollinger Band Touch | Weakness | 0.50% |
| Alert | Time |
|---|---|
| Possible NR7 | about 15 hours ago |
| Rose Above Previous Day's High | about 20 hours ago |
| Up 2% | about 20 hours ago |
| Up 1% | about 20 hours ago |
| Rose Above Lower Bollinger Band | about 20 hours ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/07/2024
Verona Pharma plc, a clinical stage biopharmaceutical company, researches, discovers, and develops therapeutic drugs to treat respiratory diseases primarily in the United Kingdom and North America. The company's lead product is RPL554, an inhaled dual inhibitor of the enzymes phosphodiesterase 3 and 4, which is in Phase IIa clinical trial that acts as a bronchodilator and an anti-inflammatory agent for the treatment of chronic obstructive pulmonary disease, cystic fibrosis, and asthma. Verona Pharma plc is based in London, the United Kingdom.
Sector: Healthcare
Industry: Biotechnology
Keywords: Asthma Respiratory Therapy Chronic Obstructive Pulmonary Disease Respiratory Diseases Cystic Fibrosis Phosphodiesterase Lung Disorders
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Asthma Respiratory Therapy Chronic Obstructive Pulmonary Disease Respiratory Diseases Cystic Fibrosis Phosphodiesterase Lung Disorders
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 23.07 |
| 52 Week Low | 11.83 |
| Average Volume | 430,052 |
| 200-Day Moving Average | 16.48 |
| 50-Day Moving Average | 15.76 |
| 20-Day Moving Average | 15.14 |
| 10-Day Moving Average | 14.74 |
| Average True Range | 0.60 |
| RSI (14) | 30.56 |
| ADX | 25.17 |
| +DI | 9.16 |
| -DI | 27.87 |
| Chandelier Exit (Long, 3 ATRs) | 14.74 |
| Chandelier Exit (Short, 3 ATRs) | 15.42 |
| Upper Bollinger Bands | 16.40 |
| Lower Bollinger Band | 13.88 |
| Percent B (%b) | 0.03 |
| BandWidth | 16.66 |
| MACD Line | -0.52 |
| MACD Signal Line | -0.38 |
| MACD Histogram | -0.1322 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 14.45 | ||||
| Resistance 3 (R3) | 14.48 | 14.35 | 14.36 | ||
| Resistance 2 (R2) | 14.35 | 14.22 | 14.33 | 14.33 | |
| Resistance 1 (R1) | 14.15 | 14.15 | 14.09 | 14.12 | 14.31 |
| Pivot Point | 14.02 | 14.02 | 13.99 | 14.00 | 14.02 |
| Support 1 (S1) | 13.82 | 13.89 | 13.76 | 13.79 | 13.59 |
| Support 2 (S2) | 13.69 | 13.82 | 13.67 | 13.57 | |
| Support 3 (S3) | 13.49 | 13.69 | 13.54 | ||
| Support 4 (S4) | 13.46 |
